Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.66, $0.01 better than the analyst estimate of $0.65. Revenue for the quarter came in at $182.7 million versus the consensus estimate of $178.84 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.